Zhengye Biotechnology (ZYBT) Stock Price, News & Analysis

Company Overview

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.

Key Stats

• Today's Range: $6.37 to $7.14
• 50-Day Range: $5.21 to $9.49
• 52-Week Range: $3.50 to $14.30
• Volume: 52,925 shs
• Average Volume: 137,548 shs
• Market Capitalization: $329.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ZYBT Stock Analysis - Frequently Asked Questions

How have ZYBT shares performed this year?

Zhengye Biotechnology's stock was trading at $4.86 at the beginning of 2025. Since then, ZYBT shares have increased by 43.6% and is now trading at $6.98.

When did Zhengye Biotechnology IPO?

Zhengye Biotechnology (ZYBT) raised $6 million in an initial public offering on Tuesday, January 7th 2025. The company issued 1,500,000 shares at a price of $4.00 per share. Kingswood Capital Partners acted as the underwriter for the IPO.

When did the company's lock-up period expire?

Zhengye Biotechnology's lock-up period expired on Monday, July 7th. Zhengye Biotechnology had issued 1,500,000 shares in its IPO on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. Since the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Who are Zhengye Biotechnology's major shareholders?

Zhengye Biotechnology's top institutional investors include Jane Street Group LLC (0.41%), Invesco Ltd. (0.08%) and Geode Capital Management LLC (0.06%).

How do I buy shares of Zhengye Biotechnology?

Shares of ZYBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ZYBT
• Previous Symbol: NASDAQ:ZYBT
• CIK: 1975641
• Web: www.jlzybio.com
• Phone: 86-13844801919
• Fax: N/A
• Employees: 278
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 1.31
• Quick Ratio: 0.88

Sales & Book Value

• Annual Sales: $25.53 million
• Price / Sales: 12.90
• Cash Flow: $0.08 per share
• Price / Cash Flow: 92.10
• Book Value: $1.02 per share
• Price / Book: 6.84

Miscellaneous

• Outstanding Shares: 47,170,000
• Free Float: N/A
• Market Cap: $329.25 million
• Optionable: N/A
• Beta: N/A